The East Village Opera Company, by Georges Bizet, Alfredo Catalani, Leo Delibes, Wolfgang Amadeus Mozart, Giacomo Puccini, Henry Purcell, Giuseppe Verdi, Peter Kiesewalter, East Village Opera Company, and Orchestr Ceská Filharmonie -- $11.99
Just when Advancis Pharmaceutical is back on track with its lead drug, the Germantown company finds itself potentially derailed by a legal dispute over its name.
Sanofi-Aventis strengthens its commitment with the World Health Organization (WHO) to fight certain neglected tropical diseases affecting the world's poorest populations. A new agreement was signed today in Geneva, by Jean-François Dehecq, Chairman and Chief Executive Officer of sanofi-aventis, and Anders Nordström, acting Director General of WHO. [click link for full article]
Based on the recommendation of the Steering Committee of the study evaluating the oral anticancer therapy, S-1, in adjuvant gastric cancer, Taiho and sanofi-aventis announced today positive interim efficacy analysis demonstrating superior efficacy benefit reported in the S-1 arm. [click link for full article]
PARIS – French drugmaker Sanofi-Aventis has refuted rumors that it has designs on embattled U.S. biotechnology company ImClone Systems Inc. ImClone had revealed on October 4 that it had received a takeover offer and media reports had speculated that Sanofi was its suitor.
BUDAPEST. OCTOBER 10. INTERFAX CENTRAL EUROPE - French pharmaceutical manufacturer Sanofi-Aventis is on schedule with ongoing investment projects in Hungary, although future investments will depend on how the Hungarian business environment develops, Sanofi-Aventis Hungary CEO Frederic Ollier told Interfax in an interview.
The European drug giant Sanofi-Aventis was the mystery bidder for the biotechnology company ImClone Systems last month, people involved in the transaction said yesterday.